HUSCAP logo Hokkaido Univ. logo

Hokkaido University Collection of Scholarly and Academic Papers >

Sort by: In order: Results/Page Authors/Record:
Export metadata:
Showing results 1 to 5 of 5
TypeAuthor(s)TitleOther TitlesCitationCitation(alt)Issue Date
article (author version)Ito, Kenichiro; Oizumi, Satoshi; Fukumoto, Shinichi; Harada, Masao; Ishida, Takashi; Fujita, Yuka; Harada, Toshiyuki; Kojima, Tetsuya; Yokouchi, Hiroshi; Nishimura, Masaharu; Hokkaido Lung Cancer Clinical Study GroupClinical characteristics of pleomorphic carcinoma of the lung-Lung Cancer-May-2010
articleKikuchi, Hajime; Sakakibara-Konishi, Jun; Furuta, Megumi; Yokouchi, Hiroshi; Nishihara, Hiroshi; Yamazaki, Shigeo; Uramoto, Hidetaka; Tanaka, Fumihiro; Harada, Masao; Akie, Kenji; Sugaya, Fumiko; Fujita, Yuka; Takamura, Kei; Kojima, Tetsuya; Harada, Toshiyuki; Higuchi, Mitsunori; Honjo, Osamu; Minami, Yoshinori; Watanabe, Naomi; Oizumi, Satoshi; Suzuki, Hiroyuki; Ishida, Takashi; Dosaka-Akita, Hirotoshi; Isobe, Hiroshi; Munakata, Mitsuru; Nishimura, MasaharuExpression of Notch1 and Numb in small cell lung cancer-Oncotarget-7-Feb-2017
article (author version)Asahina, Hajime; Oizumi, Satoshi; Inoue, Akira; Kinoshita, Ichiro; Ishida, Takashi; Fujita, Yuka; Sukoh, Noriaki; Harada, Masao; Maemondo, Makoto; Saijo, Yasuo; Dosaka-Akita, Hirotoshi; Isobe, Hiroshi; Nukiwa, Toshihiro; Nishimura, MasaharuPhase II Study of Gefitinib Readministration in Patients with Advanced Non-Small Cell Lung Cancer and Previous Response to Gefitinib-Oncology : International Journal for Cancer Research and Treatment-Apr-2011
article (author version)Akie, Kenji; Oizumi, Satoshi; Ogura, Shigeaki; Shinagawa, Naofumi; Kikuchi, Eiki; Fukumoto, Shinichi; Harada, Masao; Kinoshita, Ichiro; Kojima, Tetsuya; Harada, Toshiyuki; Fujita, Yuka; Ohsaki, Yoshinobu; Dosaka-Akita, Hirotoshi; Isobe, Hiroshi; Nishimura, MasaharuPhase II Study of Irinotecan plus S-1 Combination for Previously Untreated Advanced Non-Small Cell Lung Cancer: Hokkaido Lung Cancer Clinical Study Group Trial (HOT) 0601-Oncology-Oct-2011
article (author version)Ikezawa, Yasuyuki; Asahina, Hajime; Oizumi, Satoshi; Watanabe, Masahiro; Takamura, Kei; Kawai, Yasutaka; Yamada, Noriyuki; Harada, Toshiyuki; Kinoshita, Ichiro; Fujita, Yuka; Miyauchi, Eisaku; Ogi, Takahiro; Amano, Toraji; Furuta, Megumi; Sakakibara-Konishi, Jun; Nishihara, Hiroshi; Dosaka-Akita, Hirotoshi; Isobe, Hiroshi; Nishimura, MasaharuA randomized phase II trial of erlotinib vs. S-1 as a third- or fourth-line therapy for patients with wild-type EGFR non-small cell lung cancer (HOT1002)A randomized phase II trial of erlotinib versus S-1 as a third- or fourth-line therapy for patients with wild-type EGFR non-small cell lung cancer (HOT1002)Cancer chemotherapy and pharmacology-Nov-2017
Showing results 1 to 5 of 5

 

Feedback - Hokkaido University